Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05031234
Other study ID # 2020-A02585-34
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 17, 2020
Est. completion date February 17, 2023

Study information

Verified date December 2023
Source GCS Ramsay Santé pour l'Enseignement et la Recherche
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluation of the benefit of non-opioid general anaesthesia on postoperative pain in laparoscopic colonic surgery


Description:

Single-centre prospective randomised study carried out in two parallel groups of patients undergoing laparoscopic colectomy. - Group 1: conventional general anaesthesia with morphine - Group 2: general anaesthesia without opiates


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date February 17, 2023
Est. primary completion date February 17, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient over 18 years of age who has read and signed the consent form for participation in the study - Patient candidate for laparoscopic colectomy (planned or emergency) with possible conversion to laparotomy Exclusion Criteria: - Severe renal failure with baseline clearance<30, hepatic failure with baseline PT<40%, cardiac failure with LVEF<20%. - Patient under court protection, guardianship or curatorship - Pregnant or breastfeeding patient - Patient not affiliated to the French social security system - Impossible to give the subject informed information and/or to give written informed consent: dementia, psychosis, disturbed consciousness, non-French speaking patient - Contraindication to anaesthesia or to the administration of one of the products used in the anaesthesia protocol - Patient participating in another interventional research or in a period of exclusion from a previous research

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
anaesthesia without opiates
Anaesthesia without opiates for patients undergoing laparoscopic colectomy
anaesthesia with morphine
anaesthesia with morphine for patients undergoing laparoscopic colectomy

Locations

Country Name City State
France Hôpital Privé Médipôle Villeurbanne

Sponsors (1)

Lead Sponsor Collaborator
GCS Ramsay Santé pour l'Enseignement et la Recherche

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Morphine Use All intravenous and oral morphine consumed in the first 48 hours after surgery 48 hours
Secondary Postoperative pain H12 Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. Hour 12
Secondary Postoperative pain H24 Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. Hour 24
Secondary Postoperative pain H36 Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. Hour 36
Secondary Postoperative pain H48 Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. Hour 48
Secondary Postoperative pain D30 Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. Day 30
Secondary Mean arterial pressure Mean arterial pressure (MAP) (mmHg) 48 hours
Secondary Mean arterial pressure variability MAP variability in percentage 48 hours
Secondary Duration of Mean arterial pressure <65 Duration of Mean arterial pressure <65 mmHg (min) 48 hours
Secondary Duration of Mean arterial pressure <55 Duration of Mean arterial pressure <65 mmHg (min) 48 hours
Secondary Average heart rate Average heart rate 48 hours
Secondary Heart rate variability Heart rate variability in percentage 48 hours
Secondary Bradycardia duration < 50 Bradycardia duration < 50 (min) 48 hours
Secondary Atropine dose administered Atropine dose administered (mg) 48 hours
Secondary Ephedrine dose administered Ephedrine dose administered (mg) 48 hours
Secondary Noradrenaline dose administered Noradrenaline dose administered (ug) 48 hours
Secondary Neosynephrine dose administered Neosynephrine dose administered (ug) 48 hours
Secondary Urapidil dose Urapidil dose (mg) 48 hours
Secondary Nicardipine dose Nicardipine dose (mg) 48 hours
Secondary Postoperative hypoxemia Postoperative hypoxemia (Yes/No) 48 hours
Secondary Consumption of non-morphine drug Consumption of NSAIDs, nefopam, tramadol, ondansetron and other antiemetics Day 90
Secondary Assessment of tolerance All adverse events will be collected and compared between the 2 groups Day 90
Secondary Assessment of disability Assessment of disability with the World Health Organization Disability Assessment Schedule (WHODAS2.0) Day 30
Secondary Assessment of disability Assessment of disability with the World Health Organization Disability Assessment Schedule (WHODAS2.0). Evolution between Day 30 and Day 90. Day 90
Secondary Time to extubation, time to resumption of transit, time to onset of first gas, length of stay in ICU and total length of hospital stay Time to extubation, time to resumption of transit, time to onset of first gas, length of stay in ICU and total length of hospital stay Day 90 at least
Secondary Immediate postoperative hypoxemia Immediate postoperative hypoxemia Day 1
Secondary Oxygen requirement Oxygen requirement (yes/no at D0, D1, D2) Day 2
See also
  Status Clinical Trial Phase
Completed NCT02065661 - Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator) N/A
Completed NCT00827931 - Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery Phase 4
Terminated NCT00139607 - Parecoxib In Post Surgery (Hemicolectomy) Pain Phase 3
Completed NCT03827291 - QL Block With Exparel in Colectomy Phase 4
Completed NCT02543190 - System-Wide Improvement for Transitions After Surgery: The SWIFT Post op Program N/A
Completed NCT00911391 - Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy Phase 3
Recruiting NCT03650517 - Minimally Invasive Right Colectomy Anastomosis Study
Terminated NCT03638635 - Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients Phase 4
Recruiting NCT03722121 - Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
Completed NCT01079442 - Coffee Trial - Does Coffee Intake Reduce Postoperative Ileus After Elective Colectomy? N/A
Completed NCT00531739 - SurgiWrapTM to Reduce Soft Tissue Attachment & Incidence Early Post-Operative Bowel Obstruction in Colorectal Surgery Phase 4
Recruiting NCT03552913 - Enhanced Recovery After Surgery for Total Knee Arthroplasty, Left Colectomy and Hysterectomy
Completed NCT02509910 - Implementation of a GDT Algorithm for Major Surgery Patients N/A
Completed NCT04845334 - Complementary and Alternative Medicine Interventions in Targeting Pain N/A
Completed NCT03990714 - Intracorporeal Vs Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy N/A
Recruiting NCT05200806 - A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy Phase 4
Completed NCT03216239 - SIBO & SIFO After Colectomy
Not yet recruiting NCT02596516 - A Comparison of Colonic Bile Acid Content Following Right and Left Colectomies N/A
Active, not recruiting NCT05150548 - Predictive Time-to-Event Model for Major Medical Complications After Colectomy
Recruiting NCT03367988 - Opioid Free Anesthesia vs. Opioid Anesthesia Techniques. Phase 2/Phase 3